EFDID: 351902EFD: View Filing

Issuer: Olema Pharmaceuticals, Inc. (0001750284) - D

Accession: 0001739074-20-000012 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001750284
  • Entity Name:
    Olema Pharmaceuticals, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    512 2ND STREET, 4TH FLOOR
    SAN FRANCISCO, CA 94107
  • Persons:
    Related Persons 13
    Sean Bohen
    Executive Officer, Director
    Cynthia Butitta
    Director
    Ian Clark
    Director
    Cyrus Harmon
    Executive Officer, Director
    Gorjan Hrustanovic
    Director
    Frank McCormick
    Director
    Andrew Rappaport
    Director
    Graham Walmsley
    Director
    Shane Kovacs
    Executive Officer
    Peter Kushner
    Executive Officer
    David Myles
    Executive Officer
    Kinney Horn
    Executive Officer
    John Moriarty
    Executive Officer
EDGAR: Offering Information
  • Accession Date:
    10/13/2020
  • First Sale Date:
    09/30/2020
  • Offering Amount:
    $87,437,914
  • Amount Sold:
    $87,437,914
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:MA, NC
Inactive:CO
EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
OM Co-Investment LLC None Cowen and Company, LLC 7616 All States
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Olema Pharmaceuticals, Inc./s/ Shane KovacsShane KovacsCFO2020-10-13